Anna Morris KC addresses Module 4 Preliminary Hearing in Covid-19 Inquiry

14 September 2023

Anna Morris KC and Christian Weaver, instructed by Terry Wilcox at Hudgells Solicitors, represent over 1,000 people who have suffered an adverse reaction or bereavement as a result of the Covid-19 vaccine.

Yesterday, in their opening statement to the UK Covid-19 Inquiry preliminary hearing for Module 4, which will focus on vaccines and therapeutics, they highlighted the historic opportunity the Inquiry has to listen, acknowledge and record the experiences of the vaccine injured, and to radically reform the medical, psychological and financial support they receive.

Anna Morris KC leads the team which represents the Vaccine Injured and Bereaved UK, Scottish Vaccine Injury Group, and UK CV Family, alongside GCN’s Christian Weaver and Mark Bradley from Deans Court Chambers.

You can read a transcript of the hearing.

Media coverage of Anna’s appearance can be found below:
Daily Mail Online
The Herald

News

News

‘Candour & Communities’: Centre for People’s Justice launch Hillsborough Law exhibition

The ‘Candour & Communities’ exhibition details 100 years of state-related disasters and explains Hillsborough Law to the public.

News

Bethany Currie successfully defends Ground 15A possession claim for vulnerable client

The possession claim was heard at Birmingham County Court (pictured) in December 2025. Credit: Michael715 / Shutterstock.   Garden Court North’s Bethany Currie has successfully...

News

‘Justice, Policing & Knowing Your Rights’ – Christian Weaver appears on VOICEBOX Podcast

Garden Court North’s Christian Weaver appeared on The VOICEBOX Podcast to discuss legal literacy, modern policing and more.

News

Professor Javaid Rehman addresses IBA webinar over international legal obligations to end child marriage

Garden Court North’s Professor Javaid Rehman addressed the International Bar Association's webinar on child marriage.

Sign up to our mailing list

Our mailing list is dedicated to professionals with an interest in our work.

Sign up